Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
Results for
"[search-keyword]"
Sponsor content
25 result(s) found, displaying 1 to 10
-
Australian Public Assessment Report (AusPAR)Xeomin (incobotulinumtoxinA) has been approved for the treatment of chronic sialorrhea (hypersalivation or excessive drooling) in children and adults.
-
Apr-2024Prescription medicine evaluationActive ingredient: incobotulinumtoxinA.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Merz Australia Pty Ltd - Belotero Revive - Dermal tissue reconstructive material, microbe-derived.
-
Prescription medicine registrationActive ingredients: incobotulinumtoxinA.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Merz Australia Pty Ltd - Radiesse (+) Lidocaine - Dermal tissue reconstructive material, synthetic mineral, anaesthetic.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Merz Australia Pty Ltd - Belotero Lips Shape - Synthetic-fluid tissue reconstructive material, anaesthetic.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Merz Australia Pty Ltd - Belotero Lips Contour - Synthetic-fluid tissue reconstructive material, anaesthetic.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Merz Australia Pty Ltd - Belotero Soft Lidocaine - Synthetic-fluid tissue reconstructive material, anaesthetic.
-
Cancellation by sponsorRequested by Merz Australia Pty Ltd
-
Cancellation by sponsorRequested by Merz Australia Pty Ltd